Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
160 studies found for:    Open Studies | "Mycoses"
Show Display Options
Rank Status Study
21 Recruiting Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Condition: Fungal Infection
Interventions: Drug: APX001 single IV dose;   Drug: APX001 single oral dose 1;   Drug: APX001 single oral dose 2;   Drug: APX001 single oral dose 3;   Drug: APX001 single oral dose fasted;   Drug: APX001 single oral dose fed;   Drug: APX001 multiple oral doses 1;   Drug: APX001 multiple oral doses 2;   Drug: APX001 multiple oral doses 3;   Drug: Cytochrome P450 substrates;   Drug: Matching placebo control
22 Recruiting Safety, Tolerability and Pharmacokinetics of APX001 Administered Intravenously
Condition: Fungal Infection
Interventions: Drug: APX001 single dose 1;   Drug: APX001 single dose 2;   Drug: APX001 single dose 3;   Drug: APX001 single dose 4;   Drug: APX001 single dose 5;   Drug: APX001 single dose 6;   Drug: APX001 multiple dose 1;   Drug: APX001 multiple dose 2;   Drug: APX001 multiple dose 3;   Drug: APX001 multiple dose 4;   Drug: Matching Placebo
23 Recruiting Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Condition: Fungal Infections
Intervention: Drug: Posaconazole
24 Recruiting Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Conditions: Solid Tumors;   Mycosis Fungoides;   Melanoma;   Merkel-cell Carcinoma;   Squamous Cell Carcinoma;   Breast Carcinoma;   Human Papillomavirus-Related Malignant Neoplasm;   Soft Tissue Sarcoma
Intervention: Drug: TTI-621
25 Not yet recruiting Cost-Effectiveness of Amphotericin B
Condition: Invasive Fungal Infections
Intervention: Other: None intervention
26 Recruiting Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Conditions: Leukemia;   Transplantation, Hematopoietic Stem Cell
Intervention: Drug: Caspofugin based combination therapy
27 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
28 Recruiting Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
Condition: APECED
Intervention:
29 Not yet recruiting Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
Condition: Systemic Fungal Infections
Intervention: Drug: Posaconazole
30 Recruiting Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
Conditions: Invasive Fungal Infection;   Hematological Malignancy;   Receipt of Solid Organ Transplant
Intervention: Other: Fungitell Assay in BAL
31 Recruiting Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Conditions: Lymphoma, T-Cell, Cutaneous;   Mycosis Fungoides
Interventions: Drug: Methotrexate;   Drug: Interferon Alfa-2b
32 Not yet recruiting Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate;   Drug: Clotrimazole + Dexamethasone acetate
33 Recruiting Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Condition: Aspergillosis
Interventions: Drug: Posaconazole;   Drug: Voriconazole
34 Not yet recruiting Cell-free Circulating DNA in Primary Cutaneous Lymphomas
Conditions: Mycosis Fungoides;   Lymphoma, Large B-cell, Diffuse
Intervention: Genetic: Cytogenetic and molecular studies
35 Recruiting STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia
Conditions: Candidemia;   Mycoses;   Fungal Infection;   Fungemia
Interventions: Drug: CD101 Injection;   Drug: Caspofungin;   Drug: Fluconazole;   Drug: intravenous placebo;   Drug: oral placebo
36 Recruiting T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Conditions: Psoriasis;   Mycosis Fungoides
Intervention:
37 Recruiting Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)
Conditions: Fungal Infection;   Critical Illness
Intervention: Other: Biomarker group
38 Not yet recruiting Fungal Infection on a Joint Prosthesis
Condition: Fongal Infection
Intervention:
39 Recruiting Pharmacologic Optimization of Voriconazole
Conditions: Invasive Fungal Infection;   Hematological Malignancy
Interventions: Drug: voriconazole;   Drug: voriconazole (dosing according to the SPC)
40 Recruiting Studies of Disorders With Increased Susceptibility to Fungal Infections
Conditions: Primary Immune Deficiency;   Candida;   Autoimmune Polyendocrinopathy Candidiasis Ectodermal;   Chronic Mucocutaneous Candidiasis (CMC);   Fungal Infection
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.